Cargando…

Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still’s disease: A STROBE-Compliant prospective observational study

This study was performed to investigate the role of neutrophil-to-lymphocyte ratio (NLR) in the diagnosis of adult onset Still disease (AOSD) and its performance to improve the sensitivity of the classifications criteria (Yamaguchi and Fautrel Classifications). We conducted a multicenter prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Daghor Abbaci, Karima, Ait Hamadouche, Nadia, Otmani, Fifi, Dahou Makhloufi, Chafia, Mechid, Farida, Makrelouf, Mohamed, Otmane, Amel, Smail, Nourredine, Boucelma, Malika, Aissat, Fatma Zohra, Lefkir-Teffiani, Salima, Bengana, Bilel, Boukheris, Nadia, Tebaibia, Amar, Taharbouchet, Baya, Ayoub, Soraya, Benziane, Brahim, Oumnia, Nadia, Haouichet, Chafika, Hanni, Fella, Laraba, Nazim, Hakem, Djennete, Benfenatki, Nacera, Berrah, Abdelkrim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371519/
https://www.ncbi.nlm.nih.gov/pubmed/35960098
http://dx.doi.org/10.1097/MD.0000000000029970
_version_ 1784767166669651968
author Daghor Abbaci, Karima
Ait Hamadouche, Nadia
Otmani, Fifi
Dahou Makhloufi, Chafia
Mechid, Farida
Makrelouf, Mohamed
Otmane, Amel
Smail, Nourredine
Boucelma, Malika
Aissat, Fatma Zohra
Lefkir-Teffiani, Salima
Bengana, Bilel
Boukheris, Nadia
Tebaibia, Amar
Taharbouchet, Baya
Ayoub, Soraya
Benziane, Brahim
Oumnia, Nadia
Haouichet, Chafika
Hanni, Fella
Laraba, Nazim
Hakem, Djennete
Benfenatki, Nacera
Berrah, Abdelkrim
author_facet Daghor Abbaci, Karima
Ait Hamadouche, Nadia
Otmani, Fifi
Dahou Makhloufi, Chafia
Mechid, Farida
Makrelouf, Mohamed
Otmane, Amel
Smail, Nourredine
Boucelma, Malika
Aissat, Fatma Zohra
Lefkir-Teffiani, Salima
Bengana, Bilel
Boukheris, Nadia
Tebaibia, Amar
Taharbouchet, Baya
Ayoub, Soraya
Benziane, Brahim
Oumnia, Nadia
Haouichet, Chafika
Hanni, Fella
Laraba, Nazim
Hakem, Djennete
Benfenatki, Nacera
Berrah, Abdelkrim
author_sort Daghor Abbaci, Karima
collection PubMed
description This study was performed to investigate the role of neutrophil-to-lymphocyte ratio (NLR) in the diagnosis of adult onset Still disease (AOSD) and its performance to improve the sensitivity of the classifications criteria (Yamaguchi and Fautrel Classifications). We conducted a multicenter prospective nationwide case-control study in Internal medicine, Rheumatology and Infectious disease departments, to include successively patients with suspected AOSD (2 or more major criteria of Yamaguchi or Fautrel classifications). All clinical and biological features were collected in a consensual and standardized clinical assessment at baseline and during follow-up. A receiving operating characteristic (ROC) curve was used to reassess the cutoff value of NLR. After determination of the cutoff value for NLR by ROC curve, 2 composite sets (Yamaguchi classification + NLR as a major criterion and Fautrel classification + NLR as a major criterion) were performed and evaluated. One hundred sixty patients were included, 80 patients with AOSD and 60 controls with different diagnoses. Twenty patients with incomplete data were excluded. The cutoff value for NLR equals 4 (area under the curve, AUC: 0.82). The NLR was ≥ 4 in 93.7% (75/80) of AOSD patients with a sensitivity of 93.8% and specificity of 61.7%. The association of NLR as a major criterion with the classification of Yamaguchi or Fautrel improved their sensitivity, respectively for Fautrel (76.3% to 92.5%, P = .004) and Yamaguchi (78.8% to 90%, P = .05). This study validates the NLR as a good simple biomarker of AOSD with a cutoff value of 4 and high sensitivity (93.8%). The addition of NLR (NLR ≥ 4) as a major criterion to the classifications (Yamaguchi and Fautrel) improved significantly their sensitivity and accuracy.
format Online
Article
Text
id pubmed-9371519
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-93715192022-08-16 Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still’s disease: A STROBE-Compliant prospective observational study Daghor Abbaci, Karima Ait Hamadouche, Nadia Otmani, Fifi Dahou Makhloufi, Chafia Mechid, Farida Makrelouf, Mohamed Otmane, Amel Smail, Nourredine Boucelma, Malika Aissat, Fatma Zohra Lefkir-Teffiani, Salima Bengana, Bilel Boukheris, Nadia Tebaibia, Amar Taharbouchet, Baya Ayoub, Soraya Benziane, Brahim Oumnia, Nadia Haouichet, Chafika Hanni, Fella Laraba, Nazim Hakem, Djennete Benfenatki, Nacera Berrah, Abdelkrim Medicine (Baltimore) Research Article This study was performed to investigate the role of neutrophil-to-lymphocyte ratio (NLR) in the diagnosis of adult onset Still disease (AOSD) and its performance to improve the sensitivity of the classifications criteria (Yamaguchi and Fautrel Classifications). We conducted a multicenter prospective nationwide case-control study in Internal medicine, Rheumatology and Infectious disease departments, to include successively patients with suspected AOSD (2 or more major criteria of Yamaguchi or Fautrel classifications). All clinical and biological features were collected in a consensual and standardized clinical assessment at baseline and during follow-up. A receiving operating characteristic (ROC) curve was used to reassess the cutoff value of NLR. After determination of the cutoff value for NLR by ROC curve, 2 composite sets (Yamaguchi classification + NLR as a major criterion and Fautrel classification + NLR as a major criterion) were performed and evaluated. One hundred sixty patients were included, 80 patients with AOSD and 60 controls with different diagnoses. Twenty patients with incomplete data were excluded. The cutoff value for NLR equals 4 (area under the curve, AUC: 0.82). The NLR was ≥ 4 in 93.7% (75/80) of AOSD patients with a sensitivity of 93.8% and specificity of 61.7%. The association of NLR as a major criterion with the classification of Yamaguchi or Fautrel improved their sensitivity, respectively for Fautrel (76.3% to 92.5%, P = .004) and Yamaguchi (78.8% to 90%, P = .05). This study validates the NLR as a good simple biomarker of AOSD with a cutoff value of 4 and high sensitivity (93.8%). The addition of NLR (NLR ≥ 4) as a major criterion to the classifications (Yamaguchi and Fautrel) improved significantly their sensitivity and accuracy. Lippincott Williams & Wilkins 2022-08-12 /pmc/articles/PMC9371519/ /pubmed/35960098 http://dx.doi.org/10.1097/MD.0000000000029970 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle Research Article
Daghor Abbaci, Karima
Ait Hamadouche, Nadia
Otmani, Fifi
Dahou Makhloufi, Chafia
Mechid, Farida
Makrelouf, Mohamed
Otmane, Amel
Smail, Nourredine
Boucelma, Malika
Aissat, Fatma Zohra
Lefkir-Teffiani, Salima
Bengana, Bilel
Boukheris, Nadia
Tebaibia, Amar
Taharbouchet, Baya
Ayoub, Soraya
Benziane, Brahim
Oumnia, Nadia
Haouichet, Chafika
Hanni, Fella
Laraba, Nazim
Hakem, Djennete
Benfenatki, Nacera
Berrah, Abdelkrim
Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still’s disease: A STROBE-Compliant prospective observational study
title Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still’s disease: A STROBE-Compliant prospective observational study
title_full Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still’s disease: A STROBE-Compliant prospective observational study
title_fullStr Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still’s disease: A STROBE-Compliant prospective observational study
title_full_unstemmed Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still’s disease: A STROBE-Compliant prospective observational study
title_short Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still’s disease: A STROBE-Compliant prospective observational study
title_sort validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset still’s disease: a strobe-compliant prospective observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371519/
https://www.ncbi.nlm.nih.gov/pubmed/35960098
http://dx.doi.org/10.1097/MD.0000000000029970
work_keys_str_mv AT daghorabbacikarima validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT aithamadouchenadia validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT otmanififi validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT dahoumakhloufichafia validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT mechidfarida validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT makreloufmohamed validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT otmaneamel validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT smailnourredine validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT boucelmamalika validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT aissatfatmazohra validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT lefkirteffianisalima validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT benganabilel validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT boukherisnadia validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT tebaibiaamar validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT taharbouchetbaya validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT ayoubsoraya validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT benzianebrahim validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT oumnianadia validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT haouichetchafika validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT hannifella validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT larabanazim validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT hakemdjennete validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT benfenatkinacera validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy
AT berrahabdelkrim validationoftheneutrophiltolymphocyteratioasanewsimplebiomarkerofadultonsetstillsdiseaseastrobecompliantprospectiveobservationalstudy